SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-047638
Filing Date
2022-08-15
Accepted
2022-08-12 21:58:25
Documents
64
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0622_adialpharm.htm   iXBRL 10-Q 687591
2 CERTIFICATION f10q0622ex31-1_adialpharm.htm EX-31.1 10998
3 CERTIFICATION f10q0622ex31-2_adialpharm.htm EX-31.2 11104
4 CERTIFICATION f10q0622ex32-1_adialpharm.htm EX-32.1 4447
5 CERTIFICATION f10q0622ex32-2_adialpharm.htm EX-32.2 4437
  Complete submission text file 0001213900-22-047638.txt   3978882

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE adil-20220630.xsd EX-101.SCH 56304
7 XBRL CALCULATION FILE adil-20220630_cal.xml EX-101.CAL 28110
8 XBRL DEFINITION FILE adil-20220630_def.xml EX-101.DEF 187280
9 XBRL LABEL FILE adil-20220630_lab.xml EX-101.LAB 433985
10 XBRL PRESENTATION FILE adil-20220630_pre.xml EX-101.PRE 204200
58 EXTRACTED XBRL INSTANCE DOCUMENT f10q0622_adialpharm_htm.xml XML 405563
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38323 | Film No.: 221162036
SIC: 2834 Pharmaceutical Preparations